Cataract Surgery in HIV Seropositive Patients: Long-Term Follow-Up

REFERENCES

• Hogg RS, Yip B, Kully C, et al. Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens. CMAJ. 1999;160:659–665.
   PubMed Web of Science ®Google Scholar
• Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study investigators. N Engl J Med. 1998;338:853–860.
   PubMed Web of Science ®Google Scholar
• Lima VD, Hogg RS, Harrigan PR, et al. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. AIDS. 2007;21:685–692.
   PubMed Web of Science ®Google Scholar
• Martinez E, Milinkovic A, Buira E, et al. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area. HIV Med. 2007;8:251–258.
   PubMed Web of Science ®Google Scholar
• Mocroft A, Brettle R, Kirk O, et al. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS. 2002;16:1663–1671.
   PubMed Web of Science ®Google Scholar
• Lewden C, Salmon D, Morlat P, et al.:Mortality 2000 study group. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol. 2005;34:121–130.
   PubMed Web of Science ®Google Scholar
• Hemkens LG, Bucher HC. HIV infection and cardiovascular disease. Eur Heart J. 2014;35:1373–1381.
   PubMed Web of Science ®Google Scholar
• Pathai S, Bajillan H, Landay AL, High KP. Is HIV a model of accelerated or accentuated aging. J Gerontol A BiolSci Med Sci. 2014;69:833–842.
   PubMed Web of Science ®Google Scholar
• Desai S, Landay A. Early immune senescence in HIV disease. Curr HIV/AIDS Rep. 2010;7:4–10.
   PubMedGoogle Scholar
• Calmy A, Hirschel B, Cooper DA, Carr A. Clinical update: adverse effects of antiretroviral therapy. Lancet. 2007;370:12–14.
   PubMed Web of Science ®Google Scholar
• Rasmussen LD, Kessel L, Molander LD, et al. Risk of cataract surgery in HIV-infected individuals: a Danish Nationwide population-based cohort study. Clin Infect Dis. 2011;53:1156–1163.
   PubMed Web of Science ®Google Scholar
• Kempen JK, Sugar EA, Lyon AT, et al. Risk of cataract in persons with cytomegalovirus retinitis and the acquired immune deficiency syndrome. Ophthalmology. 2012;119:2343–2350.
   PubMed Web of Science ®Google Scholar
• Kempen JH, Sugar EA, Varma R, et al. Risk of cataract among subjects with acquired immune deficiency syndrome free of ocular opportunistic infections. Ophthalmology. 2014;121:2317–2324.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group: standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–516.
   PubMed Web of Science ®Google Scholar
• Accorinti M, Pirraglia MP, Corradi R, Corsi C, Fabiani C, Pivetti-Pezzi P. Changing patterns of ocular manifestations in HIV seropositive patients treated with HAART. Eur J Ophthalmol. 2006;16:728–732.
   PubMed Web of Science ®Google Scholar
• Klein BE, Klein R, Moss SE. Prevalence of cataracts in a population-based study of persons with diabetes mellitus. Ophthalmology. 1985;92:1191–1196.
   PubMed Web of Science ®Google Scholar
• Machan CM, Hrynchak PK, Irving EL. Age-related cataract is associated with type 2 diabetes and statin use. Optom Vis Sci. 2012;89:1165–1171.
   PubMed Web of Science ®Google Scholar
• Klein BE, Klein R, Lee KE. Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the beaver dam eye study. Am J Ophthalmol. 1998;126:782–790.
   PubMed Web of Science ®Google Scholar
• Li L, Wan XH, Zhao GH. Meta-analysis of the risk of cataract in type 2 diabetes. BMC Ophthalmol. 2014 Jul 24;14:94.
   PubMed Web of Science ®Google Scholar
• Park S, Lee EH. Association between metabolic syndrome and age-related cataract. Int J Ophthalmol. 2015;8:804–811.
   PubMed Web of Science ®Google Scholar
• Ghaem Maralani H, Tai BC, Wong TY, et al. Metabolic syndrome and risk of age-related cataract over time: an analysis of interval-censored data using a random-effects model. Invest Ophthalmol Vis Sci. 2013;54:641–646.
   PubMed Web of Science ®Google Scholar
• Lindblad BE, Håkansson N, Philipson B, Wolk A. Metabolic syndrome components in relation to risk of cataract extraction: a prospective cohort study of women. Ophthalmology. 2008;115:1687–1692.
   PubMed Web of Science ®Google Scholar
• Hiller R, Podgor MJ, Sperduto RD, et al. Longitudinal study of body mass index and lens opacities. The Framingham Studies. Ophthalmology. 1998;105:1244–1250.
   PubMed Web of Science ®Google Scholar
• Glynn RJ, Christen WG, Manson JE, Bernheimer J, Hennekens CH. Body mass index. An independent predictor of cataract. Arch Ophthalmol. 1995;113:1131–1137.
   PubMed Web of Science ®Google Scholar
• Chew GW, Teoh SC, Agrawal R. Analysis and outcomes of cataract surgery in patients with Acquired Immunodeficiency Syndrome. Ocul Immunol Inflamm. 2016; 25: 535–539.
   PubMed Web of Science ®Google Scholar
• McQuillan G, Kruszon-Moran D. HIV infection in the United States household population aged 18–49 Years: results from 1999–2006. NCHS Data Brief. 2008 January;4:1–8.
   PubMedGoogle Scholar
• Pathai S, Lawn SD, Weiss HA, Cook C, Bekker LG, Gilbert CE. Increased ocular lens density in HIV-infected individuals with low nadir CD4 counts in South Africa: evidence of accelerated aging. J Acquir Immune Def Syndr. 2013;63:307–314.
   PubMed Web of Science ®Google Scholar